202 related articles for article (PubMed ID: 18690739)
1. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake.
Zhang K; Fang H; Chen Z; Taylor JS; Wooley KL
Bioconjug Chem; 2008 Sep; 19(9):1880-7. PubMed ID: 18690739
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured materials designed for cell binding and transduction.
Liu J; Zhang Q; Remsen EE; Wooley KL
Biomacromolecules; 2001; 2(2):362-8. PubMed ID: 11749193
[TBL] [Abstract][Full Text] [Related]
3. Peptide-derivatized shell-cross-linked nanoparticles. 1. Synthesis and characterization.
Becker ML; Remsen EE; Pan D; Wooley KL
Bioconjug Chem; 2004; 15(4):699-709. PubMed ID: 15264856
[TBL] [Abstract][Full Text] [Related]
4. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
Ziegler A; Blatter XL; Seelig A; Seelig J
Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
[TBL] [Abstract][Full Text] [Related]
5. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
[TBL] [Abstract][Full Text] [Related]
7. Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction.
Gump JM; June RK; Dowdy SF
J Biol Chem; 2010 Jan; 285(2):1500-7. PubMed ID: 19858185
[TBL] [Abstract][Full Text] [Related]
8. [Tracking Trojan peptides in cells].
Sagan S; Burlina F; Delaroche D; Aussedat B; Aubry S; Bolbach G; Lavielle S; Chassaing G
J Soc Biol; 2006; 200(3):213-9. PubMed ID: 17417135
[TBL] [Abstract][Full Text] [Related]
9. Heparin binding by the HIV-1 tat protein transduction domain.
Hakansson S; Jacobs A; Caffrey M
Protein Sci; 2001 Oct; 10(10):2138-9. PubMed ID: 11567105
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.
Ziegler A; Seelig J
Biophys J; 2004 Jan; 86(1 Pt 1):254-63. PubMed ID: 14695267
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors.
Yang Y; Ma J; Song Z; Wu M
FEBS Lett; 2002 Dec; 532(1-2):36-44. PubMed ID: 12459459
[TBL] [Abstract][Full Text] [Related]
12. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.
Alonso A; Derse D; Peterlin BM
J Virol; 1992 Jul; 66(7):4617-21. PubMed ID: 1602563
[TBL] [Abstract][Full Text] [Related]
13. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application.
Zhang X; Zhang X; Wang F
Expert Opin Drug Deliv; 2012 Apr; 9(4):457-72. PubMed ID: 22432469
[TBL] [Abstract][Full Text] [Related]
14. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
15. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
Shuai Q; Cai Y; Zhao G; Sun X
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
[TBL] [Abstract][Full Text] [Related]
16. The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.
Cardaci S; Soster M; Bussolino F; Marchiò S
FEBS Lett; 2013 Sep; 587(18):2943-51. PubMed ID: 23916815
[TBL] [Abstract][Full Text] [Related]
17. Surface presentation of functional peptides in solution determines cell internalization efficiency of TAT conjugated nanoparticles.
Todorova N; Chiappini C; Mager M; Simona B; Patel II; Stevens MM; Yarovsky I
Nano Lett; 2014 Sep; 14(9):5229-37. PubMed ID: 25157643
[TBL] [Abstract][Full Text] [Related]
18. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
Vivès E; Brodin P; Lebleu B
J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504
[TBL] [Abstract][Full Text] [Related]
19. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
20. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
